Alltrna logo

Alltrna

The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeutic potential within #tRNA.

49 employees · est. 2018 · Cambridge, United States

VS
Tevard Biosciences logo

Tevard Biosciences

Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.

27 employees · est. 2017 · Cambridge, United States

Tevard Biosciences is the older company (2018 vs 2017).

Side-by-Side Comparison

Alltrna Tevard Biosciences
Founded
2018 2017 older
Headquarters
Cambridge, United States Cambridge, United States
Employees
49 27
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Series B Not tracked yet
Total Funding
$159.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Development of tRNA-based therapies, Engineering programmable tRNAs, Restoration of protein production, Treatment for stop codon diseases, Scaling genetic medicine Not tracked yet
Target Customers
Patients with rare genetic diseases, Medical research communities, Healthcare providers, Biopharmaceutical companies Not tracked yet
Taxonomy
Therapeutics, TRNA Biology, Genetic Mutations, Protein Production, Rare Diseases, Common Diseases, Machine Learning Tools, Flagship Labs, Startup, Innovation, Biomedical Research, Precision Medicine, Genomics TRNA Therapeutics, MRNA Modulation, Genetic Diseases, Gene Therapy, Rare Diseases, AAV, Therapeutics, Genetic Medicine, Biomedical Innovation
Website
alltrna.com tevard.com
Alltrna logo

About Alltrna

Alltrna, founded in 2018 at Flagship Labs, is pioneering the use of transfer RNA (tRNA) to unlock vast therapeutic potentials in the field of biotechnology and health care. As the world’s first tRNA platform company, its mission is to advance tRNA therapeutics that can regulate the protein universe...

Tevard Biosciences logo

About Tevard Biosciences

Tevard Biosciences is a biotechnology startup that is pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Since its founding in 2017, the company has been focused on leveraging this innovative approach to make significant advancements in the fields of b...

We will tell you when either one moves

BounceWatch watches Alltrna and Tevard Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alltrna and Tevard Biosciences — by email.

Frequently Asked Questions

Alltrna — The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeutic potential within #tRNA.. Tevard Biosciences — Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alltrna has raised $159.00M while Tevard Biosciences has raised undisclosed funding.
Alltrna and Tevard Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alltrna with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alltrna on 9 Jun 2026, and Tevard Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy